Directly integrated with Yineng Pharma's precision extraction, analytical standardization, and modern fluid-bed agglomeration manufacturing facilities.
The global pharmaceutical and clinical nutraceutical sectors are undergoing a permanent structural migration from legacy oral solid dosage forms—such as hard gelatin capsules and heavily compressed tablets—toward instant-dispersing, highly bioavailable soluble powders. In contemporary commercial therapeutics and preventive wellness, consumer compliance hinges upon palatability, swallowing comfort (dysphagia management), rapid gastric emptying, and immediate systemic absorption. Traditional botanical extracts are notoriously challenging to formulate: raw botanical matrices are dense with hydrophobic polyphenols, insoluble lipophilic triterpenoid saponins, sticky polysaccharides, and hygroscopic tannins that aggregate into unmarketable, chalky sediment when mixed with ambient liquids.
As a specialized Chinese botanical CRO and CDMO, MedGence (Yineng Pharma) engineers soluble powder formulations that solve thermodynamic dissolution barriers at the molecular level. Leveraging over 14 years of scientific rigor, 300+ in-house formulation chemists, and deep technical collaborations with national-grade pharmaceutical institutions, we bridge the divide between crude botanical extraction and high-speed industrial soluble powder commercialization. Our ODM soluble powder platforms incorporate state-of-the-art solid dispersion (SD), inclusion complexation, and computerized fluid-bed top-spray agglomeration to transform sticky or hydrophobic phytochemicals into free-flowing, instantly dissolvable micro-granules with complete aqueous clarity.
Raw botanical powders exhibit contact angles exceeding 90°, repelling water molecules. Our process re-engineers surface tension via physiological hydrophilic carriers, dropping contact angles to under 25° for instantaneous wetting in cold liquids.
By pre-dispersing active botanicals into amorphous solid states or molecular nanomicelles within soluble carriers, the effective surface area exposed to enteric mucosa expands up to 800-fold, dramatically accelerating in vivo Cmax and AUC metrics.
Hygroscopic herbal extracts degrade rapidly under ambient humidity. Our closed-loop fluid-bed processing encapsulates sensitive actives with anti-caking functional matrices, guaranteeing 36-month shelf-life stability under strict ICH zone IVb guidelines.
Accelerating time-to-market through upstream agricultural control, multi-ton fluid-bed processing capacity, and continuous regulatory validation.
Positioned in Changsha, Hunan—the nexus of authentic Chinese medicinal plant ecosystems—we access geographically authenticated herbs directly at harvest peaks, ensuring maximum marker compound potency prior to extraction.
Equipped with 500kg-to-2000kg single-batch continuous fluid-bed agglomerators featuring top-spray nozzles and peristaltic binder micro-dosing. Process automation ensures intra-batch content uniformity (RSD < 1.5%).
Our dual R&D and CDMO architecture enables seamless scaling: from 5kg laboratory proof-of-concept batches to 10-metric-ton commercial campaigns within 21 operating days, eliminating inter-vendor transfer friction.
Vertical integration—encompassing botanical extraction, fractional crystallization, spray drying, and nitrogen-flushed high-speed sachet packing—delivers a 35–48% cost saving relative to Western contract manufacturing hubs.
Engineered for dynamic commercial channels across pharmaceuticals, medical foods (FSMP), dietary supplements, and rapid-hydration sports nutrition.
Soluble instant electrolytes integrated with adaptogenic botanical actives (e.g., standardized Panax ginseng ginsenosides, Rhodiola rosea salidroside). Dissolves crystal-clear in chilled water in under 15 seconds without foaming or gritty residue.
Taste-masked, sugar-free instant dispersible powders for age groups suffering from pill dysphagia. Natural bitterness and astringency of botanical alkaloids are trapped via molecular beta-cyclodextrin cavities, yielding child-friendly neutral flavor profiles.
Enteral tube-feeding and medical nutrition soluble powders designed with precise osmolality, low glycemic indices, and high chemical stability. Retains enzymatic activity and peptide integrity during instant aqueous reconstitution.
Derived from MedGence's proprietary library of 83 modernized classical TCM formulas. Concentrated decoctions are transformed into instantly dissolvable single-dose granules matching traditional boiling water extraction efficacy with 10x physical stability.
Moisture-controlled micro-granules utilizing precision citric acid/sodium bicarbonate stoichiometric ratios. Releases micro-carbonated effervescence in water that mechanically accelerates mucosal contact and active botanical uptake without stomach irritation.
Freeze-dried, water-soluble plant stem cell actives and botanical antioxidant complexes packed in nitrogen-flushed amber glass vials or single-use sticks, offering 100% active integrity for aesthetic and topical cosmeceutical reconstitutions.
The manufacturing paradigms governing botanical soluble powders have advanced dramatically beyond crude spray drying. Global procurement directors and brand innovators are seeking clean-label, carrier-minimized soluble systems that withstand rigorous cross-continental supply chain stresses. At MedGence, our pharmaceutical R&D team is actively deploying four generational breakthroughs in soluble powder processing:
Converting unstable liquid liposomes into free-flowing, instantly re-hydrating dry powders via low-temperature spray freeze-drying (SFD). Phospholipid bilayers protect fragile polyphenols from gastric acid degradation.
Phasing out synthetic maltodextrins and silicon dioxides in favor of functional acacia fibers, chicory inulin, and pullulan matrices that preserve solubility while meeting Clean Label Project® standards.
Process Analytical Technology (PAT) incorporating in-line Near-Infrared (NIR) sensors monitors real-time moisture kinetics during fluid-bed cycles, guaranteeing critical limits (water activity Aw < 0.25) batch after batch.
Sub-micron droplet dispersion transforms lipophilic botanical essential oils into water-soluble dry powders that yield translucent solutions without oil rings or surfactant tastes upon dilution.
Audit-ready validation data packages conforming to US FDA cGMP (21 CFR Part 111 & 211), European Pharmacopoeia (EP), and Health Canada standards.
Comprehensive Carr's Index (< 15%), Hausner Ratio (< 1.18), angle of repose (< 30°), and particle size distribution (D50 between 150–300 µm) to ensure zero jamming during automated stick-pack filling at 120 units/min.
Triple-quadrupole ICP-MS screens heavy metals (Pb < 0.5 ppm, Cd < 0.2 ppm, As < 0.5 ppm, Hg < 0.1 ppm). GC-MS/MS verifies EP 2.8.13 multi-pesticide screens (> 500 compounds) and residual solvents below USP <467> Option 1 thresholds.
Automated sanitization cycles guarantee Total Aerobic Microbial Count (TAMC) < 1,000 CFU/g, Total Yeast & Mold Count (TYMC) < 100 CFU/g, and verified absence of E. coli, Salmonella, and Staphylococcus aureus under USP <61/62>.
Every project phase is bound to unambiguous analytical deliverables, ensuring risk-free technology transfer and seamless commercial scale-up.
Screening species, regional harvest origins, and plant anatomical parts yielding peak active ingredient density.
Deliverable: Phytochemical Assay DossierValidating chromatographic fingerprints (HPLC/HPTLC/GC) to quantify marker actives and establish batch specs.
Deliverable: Method Validation Report (ICH Q2)Engineering carrier matrices, spray temperatures, and binder viscosity to lock in dissolution kinetics < 30 seconds.
Deliverable: Critical Process Parameters (CPP)Conducting LD50 acute/chronic toxicology, cellular uptake, and animal pharmacokinetic models in certified labs.
Deliverable: Complete Safety & PK Data FileManaging human efficacy trials for dietary health claims or full Phase I–IV clinical investigations for drug applications.
Deliverable: GCP Clinical Study ReportFull-scale commercial production in Class 100,000 cleanrooms with automated multi-lane nitrogen packaging.
Deliverable: Commercial Batches + CoAOur formulation research, clinical validation, and CDMO infrastructure power China's most respected pharmaceutical leaders and healthcare institutions.
Clear technical guidance for procurement directors, product developers, and regulatory affairs teams.
Engage our specialized laboratories and production units for turnkey botanical active commercialization.
Consult directly with our scientific directors in Changsha to discuss botanical active profiles, dissolution targets, and custom pilot-batch validation.
